Soluble epoxide hydrolase inhibition alleviates inflammation in cigarette smoke-induced experimental COPD irrespective of dietary fat content
S. REHMAN (Sydney, Australia), K. Budden (Newcastle, Australia), A. Quaranta (Stockholm, Sweden), D. Fuchs (Stockholm, Sweden), S. Shukla (Newcastle, Australia), A. Brown (Newcastle, Australia), C. Alemao (Newcastle, Australia), L. Balachandra (Newcastle, Australia), H. Gomez (Newcastle, Australia), V. Kumar (Newcastle, Australia), S. Idrees (Sydney, Australia), J. Horvat (Newcastle, Australia), L. Wood (Newcastle, Australia), C. Wheelock (Stockholm, Sweden), P. Hansbro (Sydney, Australia)
Source: International Congress 2022 – Elucidating the pathogenesis of COPD, cough and viral infection
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. REHMAN (Sydney, Australia), K. Budden (Newcastle, Australia), A. Quaranta (Stockholm, Sweden), D. Fuchs (Stockholm, Sweden), S. Shukla (Newcastle, Australia), A. Brown (Newcastle, Australia), C. Alemao (Newcastle, Australia), L. Balachandra (Newcastle, Australia), H. Gomez (Newcastle, Australia), V. Kumar (Newcastle, Australia), S. Idrees (Sydney, Australia), J. Horvat (Newcastle, Australia), L. Wood (Newcastle, Australia), C. Wheelock (Stockholm, Sweden), P. Hansbro (Sydney, Australia). Soluble epoxide hydrolase inhibition alleviates inflammation in cigarette smoke-induced experimental COPD irrespective of dietary fat content. 3897
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|